Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended CBD for GVHD Prevention
NCT02478424Phase 2Unknown
- Sponsor
- Rabin Medical Center
- Start
- Jul 2015
- Primary completion
- Dec 2016
01
Overview
A Phase 2 trial of cannabidiol in graft-versus-host disease (GVHD), sponsored by Rabin Medical Center. Status: unknown.
02
Drugs
cannabidiol
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT02478424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02478424.